Myb-Related Schizosaccharomyces pombe cdc5p Is Structurally and Functionally Conserved in Eukaryotes

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105

Howard Hughes Medical Institute and Department of Cell Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232; Department of Pathology and Program in Molecular and Genetic Medicine, School of Medicine, Stanford University, Stanford, California 94305; and Department of Experimental Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105